Related Experiment Videos
[Comparison between pre- and postnatal echographic screening of malformative uropathies]
1Unità Operativa di Neonatologia, Dipartimento di Ginecologia, Ostetricia, Fisiopatologia Riproduzione Umana e Neonatologia, Università degli Studi di Messina, Messina. carmelo.mami@unime.it
Minerva Ginecologica
|June 9, 2005
Summary
Postnatal screening for malformative uropathies (MU) remains significant. Prenatal echography has limitations in diagnosing these conditions, highlighting the need for continued postnatal evaluation.
Area of Science:
- Neonatal Ultrasound
- Pediatric Urology
- Diagnostic Imaging
Background:
- Prenatal diagnosis of congenital anomalies is crucial for early intervention.
- Malformative uropathies (MU) are a significant group of congenital anomalies.
- Echography is a primary imaging modality for diagnosing fetal and neonatal conditions.
Purpose of the Study:
- To compare the diagnostic accuracy of postnatal echographic screening versus prenatal echography for malformative uropathies (MU).
- To evaluate the effectiveness of fetal echography in detecting various types of MU.
- To determine the continued relevance of postnatal screening for MU.
Main Methods:
- A cohort of 6578 infants underwent both fetal echography and postnatal screening for MU.
- Diagnostic agreement between prenatal and postnatal echography was analyzed.
- Specific detection rates for pyelectasis, hydronephrosis, and non-dilated MU were calculated.
Main Results:
- Fetal echography detected only 35.71% of pyelectasies and 73.17% of hydronephrosis.
- Detection rates for non-dilated malformative uropathies by fetal echography were notably low (18.75%).
- Postnatal screening identified a substantial number of MU cases missed by prenatal imaging.
Conclusions:
- Postnatal echographic screening for malformative uropathies retains clinical significance.
- The diagnostic limitations of fetal echography necessitate continued postnatal evaluation.
- Further validation of prenatal echography's efficacy is required before discontinuing postnatal screening for MU.